- Home
- ANSS vs BNTX Comparison
ANSS vs BNTX Comparison
Compare ANSS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANSS
- BNTX
- Stock Information
- Founded
- ANSS 1970
- BNTX 2008
- Country
- ANSS United States
- BNTX Germany
- Employees
- ANSS N/A
- BNTX N/A
- Industry
- ANSS Computer Software: Prepackaged Software
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANSS Technology
- BNTX Health Care
- Exchange
- ANSS Nasdaq
- BNTX Nasdaq
- Market Cap
- ANSS 27.8B
- BNTX 23.9B
- IPO Year
- ANSS 1996
- BNTX 2019
- Fundamental
- Price
- ANSS $342.84
- BNTX $114.13
- Analyst Decision
- ANSS Hold
- BNTX Strong Buy
- Analyst Count
- ANSS 6
- BNTX 15
- Target Price
- ANSS $342.50
- BNTX $143.50
- AVG Volume (30 Days)
- ANSS 532.3K
- BNTX 659.5K
- Earning Date
- ANSS 02-19-2025
- BNTX 11-04-2024
- Dividend Yield
- ANSS N/A
- BNTX N/A
- EPS Growth
- ANSS 17.14
- BNTX N/A
- EPS
- ANSS 6.48
- BNTX N/A
- Revenue
- ANSS $2,467,743,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- ANSS $13.17
- BNTX N/A
- Revenue Next Year
- ANSS $9.54
- BNTX N/A
- P/E Ratio
- ANSS $52.90
- BNTX N/A
- Revenue Growth
- ANSS 14.30
- BNTX N/A
- 52 Week Low
- ANSS $289.82
- BNTX $76.53
- 52 Week High
- ANSS $364.31
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ANSS 51.88
- BNTX 49.15
- Support Level
- ANSS $331.47
- BNTX $109.52
- Resistance Level
- ANSS $344.81
- BNTX $115.34
- Average True Range (ATR)
- ANSS 6.51
- BNTX 4.74
- MACD
- ANSS -1.03
- BNTX -0.80
- Stochastic Oscillator
- ANSS 47.89
- BNTX 29.03
About ANSS ANSYS Inc.
Ansys is an engineering software company that provides simulation capabilities for structural, fluids, semiconductor power, embedded software, optical, and electromagnetic properties. Ansys employs over 4,000 people and serves over 50,000 customers globally, including those in aerospace defense and automotive.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.